Search results
Q1 2024 Hawaiian Electric Industries Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 hour agoLast quarter, we discussed Governor Josh Green's One 'Ohana initiative. Which is intended to help the families most impacted by the fires heel and to help our state move forward< ...
Q1 2024 Marpai Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 51 minutes agoBut that's not all. We've laser-focused on the member experience, improving service metrics like faster response times and smarter cost containment reviews. Finally, we've completed the first ...
Altimmune, Inc. (NASDAQ:ALT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 15 hours agoAltimmune, Inc. (NASDAQ:ALT) Q1 2024 Earnings Call Transcript May 9, 2024 Altimmune, Inc. isn’t one...
Intensity Therapeutics, Inc. and The Swiss Group for Clinical...Collaboration Agreement to Conduct a...
FOX 4 Kansas City· 23 hours agoIntensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development...with The ...
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in...
Fontana Herald News· 23 hours agoAethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced ...
Q1 2024 Clearside Biomedical Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 16 hours agoWe expect that the final Phase 2b data will provide important insights to create a robust Phase 3 development program for CLS-AX. I'm looking forward ...
Earnings call: Protalix BioTherapeutics Q1 2024 financial results By Investing.com
Investing.com· 17 hours agoProtalix BioTherapeutics, Inc. (PLX) has reported its first-quarter financial results for 2024,...
Q1 2024 Matinas BioPharma Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 17 hours agoThe body of evidence that MAT2203 as a life-changing therapy continues to grow. And we look forward to moving it into the Oralto Phase 3 global clinical ...
Earnings call: Oncolytics Biotech details progress in cancer studies By Investing.com
Investing.com· 19 hours agoOncolytics Biotech Inc. (NASDAQ:ONCY) shared promising updates on their cancer research and clinical...
